Design and synthesis of heterocyclic malonyl-CoA decarboxylase inhibitors

Add time:09/26/2019    Source:sciencedirect.com

We have previously reported the discovery of small molecule inhibitors of malonyl-CoA decarboxylase (MCD) as novel metabolic modulators, which inhibited fatty acid oxidation and consequently increased the glucose oxidation rates in the isolated working rat hearts. MCD inhibitors were also shown to improve cardiac efficiency in rat and pig demand-induced ischemic models through the mechanism-based modulation of energy metabolism. Herein, we describe the design and synthesis of a series of novel heterocyclic MCD inhibitors with a preference for substituted imidazole and isoxazole.

We also recommend Trading Suppliers and Manufacturers of Malonyl chloride (cas 1663-67-8). Pls Click Website Link as below: cas 1663-67-8 suppliers

Prev:Heteroaryl substituted bis-trifluoromethyl carbinols as malonyl-CoA decarboxylase inhibitors
Next:On the conformations of the Malonyl chloride (cas 1663-67-8) methyl and ethyl esters, ClC(O)CH2C(O)OCH3 and ClC(O)CH2C(O)OC2H5: Vibrational analyses, 1H NMR spectra and ab initio calculations)